UBS Group’s Edoc Acquisition Corp. Right ADOCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-132
| Closed | -$8 | – | 10303 |
|
|
2023
Q4 | $8 | Buy |
+132
| New | +$13 | ﹤0.01% | 9132 |
|
|
2023
Q3 | – | Sell |
-142
| Closed | -$18 | – | 10177 |
|
|
2023
Q2 | $18 | Sell |
142
-558
| -80% | -$85 | ﹤0.01% | 8699 |
|
|
2023
Q1 | $104 | Sell |
700
-500
| -42% | -$59 | ﹤0.01% | 9234 |
|
|
2022
Q4 | $72 | Sell |
1,200
-3,481
| -74% | -$278 | ﹤0.01% | 10440 |
|
|
2022
Q3 | $0 | Buy |
4,681
+2,000
| +75% | +$235 | ﹤0.01% | 11225 |
|
|
2022
Q2 | $0 | Sell |
2,681
-501
| -16% | -$137 | ﹤0.01% | 11228 |
|
|
2022
Q1 | $1K | Hold |
3,182
| – | – | ﹤0.01% | 9993 |
|
|
2021
Q4 | $1K | Buy |
+3,182
| New | +$1.19K | ﹤0.01% | 10081 |
|
|
2021
Q2 | – | Sell |
-427
| Closed | – | – | 9971 |
|
|
2021
Q1 | $0 | Sell |
427
-4,158
| -91% | -$1.97K | ﹤0.01% | 9611 |
|
|
2020
Q4 | $3K | Buy |
+4,585
| New | +$1.7K | ﹤0.01% | 8030 |
|
UBS Group's ADOCR Position: Q1 2024 in Review
UBS Group sold out of Edoc Acquisition Corp. Right (ADOCR) in Q1 2024, closing a stake of 132 shares — an estimated $8 sold.
UBS Group first reported a position in ADOCR in Q4 2020 and held it in 10 quarters. The position peaked at $3K in Q4 2020. 0 funds tracked by Wall St. Rank hold ADOCR as of Q1 2024.
- UBS Group reported no remaining Edoc Acquisition Corp. Right position as of Q1 2024 after selling out during the quarter.
- UBS Group sold 132 Edoc Acquisition Corp. Right shares in Q1 2024, an estimated $8.
- UBS Group first reported a position in Edoc Acquisition Corp. Right in Q4 2020 and held it in 10 quarters.
- UBS Group's Edoc Acquisition Corp. Right position peaked at $3K in Q4 2020.
- 0 funds tracked by Wall St. Rank held Edoc Acquisition Corp. Right as of Q1 2024.
Based on UBS Group's 13F filing for Q1 2024, filed 13 May 2024.